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 Polo-like kinase 4 (PLK4) belongs to the family of polo-like kinases (PLK1-5), an 
evolutionarily conserved family of serine/threonine kinases containing a characteristic 
polo box and similar architecture. PLK4 differs from the other polo-like kinases by 
possessing a structurally divergent sequence and therefore different substrate 
specificity and mechanism of action. Previous studies of PLK4 have centered on its role 
in centriole biogenesis. Overexpression of PLK4 has been shown to cause centrosome 
amplification and supernumerary centrosomes are a signature event in tumorigenesis 
and cancer. Recently, PLK4 has been implicated in the process of spermatogenesis. 
Mutation within the kinase domain of PLK4 was found to cause hypogonadism and germ 
cell loss. Our lab also reported that PLK4 localizes to the largely unsynapsed X and Y axes 
during meiotic prophase I, displaying a similar pattern to proteins involved in the 
process of meiotic sex chromosome inactivation (MSCI). These findings suggests that 
PLK4 harbors a novel role in MSCI during spermatogenesis and aberrancies in PLK4 
function leads to meiotic arrest, loss of germ cells and infertility. 
 Using the potent and reversible small molecule inhibitor of PLK4, centrinone as 
well as mutant mice bearing a mutation in the kinase domain of PLK4, we assess the 
progression of meiosis to check for defects specifically at prophase I stage while 
comparing the observations to their wild type littermates. Our data exhibits delays in 
meiotic progression as well as an indicating misregulation of DNA damage response in 
centrinone treated cells. 
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 Based on existing literature as well as findings from this study, we present strong 
evidence that the protein PLK4 has a role to play in accurate chromosome segregation 
and MSCI during prophase I of male meiosis. Inhibition or mutation of PLK4 results in 
meiotic failure which eventually leads to apoptosis and loss of germ cells. The 
mechanistic details and full repertoire of proteins and their substrates involved in this 
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OVERVIEW OF MEIOTIC PROPHASE I 
 Meiosis is an indispensable event in the formation of gametes in all sexual 
reproducing species, it involves one round of chromosome replication followed by two 
subsequent rounds of chromosome segregation - a reductive segregation in which 
homologous chromosomes separate from one another (meiosis I) and an equational 
segregation in which sister chromatids separate from each other (meiosis II) to yield 
four haploid gametes during spermatogenesis (Figure 1). During the extended meiotic 
prophase I, homologous chromosomes recognize, pair and synapse with one another 
and undergo crossover recombination, a process mediated by the unique meiotic 
scaffold called the synaptonemal complex (SC). Meiotic recombination generates 
diversity within a population and also creates the connection between homologous 
chromosomes - the chiasmata that holds the chromosomes in opposition on the meiotic 
spindle and ensure their accurate segregation. The substages of meiosis I prophase are 
defined by chromosome configurations and structure: During leptonema (leptotene 
stage), the chromatids experience genetically programmed double-strand DNA breaks 
induced by the meiotic specific topoisomerase II-like enzyme, sporulation 11 (SPO 11) 
and this provides the substrate for recombination, the homologous chromosomes begin 
to align at this stage but are not yet paired. By zygonema (zygotene stage), homologous 
chromosomes have found each other, pairing extends and synapsis is initiated. 
Pachynema (pachytene stage) is defined by completion of synapsis and 
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compartmentalization of the X and Y chromosomes into a nuclear subdomain known as 
the sex body. Chromosomes undergo desynapsis in the final diplotene stage 
(diplonema). Summarily, pairing occurs during leptotene and zygotene stages, 
autosomal synapsis is completed at pachytene stage and desynapsis occurs during 
diplotene stage (Figure 2). Correct execution of this process is essential for maintaining 
the integrity of the genome, for ensuring normal development of offspring and for 
fertility and so must be accurately regulated (Handel, 2004; Handel and Schimenti, 
2010). The regulation and control of cell division processes has been established to rely 
on the complex interplay between kinases and phosphatases which are conserved 
among species. Eukaryotic protein kinases constitute one of the largest of mammalian 
gene families, the mouse genome for example encodes 540 protein kinases. These 
kinases, by adding phosphate groups to their substrates alter the activity, location and 
lifetime of a large fraction of proteins and coordinate several complex cellular functions 
(Caenepeel et al., 2004). Key kinases known to be involved in the cell cycle progression 
include a series of conserved serine/threonine protein kinases such as the cyclin-







Figure 1: An overview of meiosis. Figure created by Dr. Phil Jordan 
 
 
Figure 2: The substages of meiosis I prophase in mammals (Handel and Schimenti, 2010) 
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POLO-LIKE KINASES – STRUCTURE AND DOMAINS  
Polo-like kinases are potent regulators of the cell cycle and are conserved from 
yeasts to humans (Archambault and Glover, 2009). They were first discovered in 
Drosophila melanogaster. Mutation of polo caused abnormal centrosomes and 
monopolar spindles (Sunkel and Glover, 1988). Single polo-like kinases were also found 
to be present in budding yeast (Saccharomyces cerevisiae) and fission yeast 
(Schizosaccharomyces pombe) as cell cycle division 5 (Cdc5) and Plo1 respectively, and 
they function to regulate mitotic entry, exit and cytokinesis. Research on this family of 
kinases after their discovery in budding yeast (Cdc5), Drosophila melanogaster (Polo) 
and mammals (polo-like kinases) have shown that they are present in all branches of the 
Eukarya and there are five paralogs in mammals- PLK1-5 (Carvalho-santos et al, 2010). 
The polo-like kinase family are serine/threonine kinases, all possessing a characteristic 
polo box and sharing similar architecture: an amino-terminal (Serine/Threonine) 
catalytic kinase domain and a carboxy-terminal region containing two or more polo 
boxes. (Kothe, M et al., 2007). Among the polo-like kinases, PLK1-3 share very similar 
catalytic domains with two polo-box domains at their C-terminus (Figure 3). PLK5 does 
not seem to have a role in cell cycle progression, and does not possess a functional 
kinase domain. However, it is detected in the cytoplasm of neurons and glia and possess 
nervous system specific functions and tumor suppressor activity in the brain and cancer 
(de Carcer et al, 2011). PLK4, sometimes referred to as SAK (Snk akin Kinase) due to its 
homology with murine Snk has been termed ‘the odd one out of the family’ (Sillibourne 
and Bornens, 2010). It is structurally divergent from PLK1-3 as it contains a single 
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carboxy terminal polo-box domain (PB3) and in place of the second polo-box it 
possesses a larger crypto polo-box domain (CPB), which includes two polo boxes (PB1 
and PB2) and forms a bridge between the kinase domain and the carboxy-terminal Polo 
box (Carvalho-Santos et al., 2010; Slevin et al., 2012; Jana et al., 2012). (Figure 3) 
The polo box domains which are characteristic of all members of the polo-like 
kinase family dictate the substrate specificity of the kinase and also regulates its 
function. PLK4, possessing a single polo-box compared to the two polo boxes of PLK1-3 
indicates a different form of regulation for PLK4. The tandem polo-boxes of PLK1-3 form 
intramolecular heterodimers which then regulates the activity of the kinase by inducing 
a conformational change and allowing the catalytic domain gain access to its substrates 
(Elia et al., 2003). In contrast, the PLK4 polo box and its crypto polo box do not form 
heterodimers. Also, while the polo boxes of PLK1-3 are important for targeting the 
kinases to particular subcellular sites, deletion of the polo domain of PLK4 did not 
abolish subcellular localization to the centrosomes and only when the polo box and 
crypto polo box were removed did it fail to localize to the centrosomes. This reflects the 
presence of a second localization domain unique to PLK4 and shows that both the polo 
box and crypto polo box of PLK4 are independently able to localize PLK4 to its substrate 
(Leung et al., 2002). PLK4 also differs from the other polo-like kinases as it possesses 
three PEST sequences which are domains rich in proline(P), aspartate(D), glutamate(E), 
serine(S) and threonine(T) residues responsible for governing the stability of the protein. 






Figure 3: Domains of polo-like kinases. PB denotes polo box; Cry-PB denotes cryptic PB 




Figure 4: The structure of Plk4 showing its PEST motifs in the numbered boxes 








POLO-LIKE KINASES –EXPRESSION, LOCALIZATION AND FUNCTIONS 
 The polo-like kinases show variations in abundance, structure, functions and 
localization at different stages of the cell cycle and are highly expressed in mammalian 
cells(Figure 5). Jordan et al, 2012 showed that the expression of mRNA transcripts for 
PLK1-4 increase with progression of the first wave of spermatogenesis with lowest 
expression prior to meiotic entry (4 days post-parturm [dpp]) and reaching a maximum 
expression level by 16 dpp which corresponds to meiotic prophase (Figure 6A). They 
also show that PLK1-4 proteins were detected throughout the first wave of 
spermatogenesis, levels of PLK1-3 are relatively low prior to meiotic entry and increase 
when prophase to metaphase I (G2/MI) transition cells are present (19-22 dpp). PLK4 on 
the other hand show highest levels at 7-16 dpp and drop during the G2/M1 transition 
(19-22 dpp). Mixed germ cells from the adult testes show lower PLK4 protein levels, 
perhaps reflecting the lower representation of meiotic cells, and the faster migrating 
band may likely be a truncated or spliced variant form of PLK4 (Figure 6B).    
Among the Polo-like kinases, PLK1 is the most characterized and is found in 
several locations throughout the mitotic cell cycle, whereas other polo-like kinases are 
restricted to specific stages and locations (Zitouni et al., 2014). PLK1 localizes to mitotic 
chromosome axes and centrosomes, centromeres, kinetochores, the spindle midzone in 
anaphase and the midbody in cytokinesis. PLK2 and PLK4 localize at or near the 
centrioles throughout the cell cycle and PLK3 localizes to the nucleolus (Abe et al., 2011; 
Archambault and Glover, 2009). Jordan et al, 2012 also show the localization pattern of 
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PLK1-4 by immunofluorescence microscopy assessment of spermatocyte nuclear 
spreads during meiosis I. At pachynema and diplonema, PLK1 signal is seen along the SC 
and by metaphase PLK1 is seen at the centromeres. PLK2 and PLK3 protein signals were 
observed throughout the chromatin in pachynema and diplonema while PLK4 signal 
localized to the sex body (Figure 7).  
 
Figure 5: PLK functions and localizations during the mammalian cell cycle                                          
(A) PLK1 functions begin in G2, where it localizes to the centrosomes. In prometaphase 
and metaphase, it is found at kinetochores and the spindle pole. It finally translocates to 
the central spindle in anaphase and telophase.                                                                                                          
(B) PLK2 and PLK4 are localized to the centrosomes where they are involved in centriole 
duplication.                                                                                                                                                   
(C) PLK3 is implicated in DNA replication, G1/S transition, G2/M transition and 





Figure 6: Expression of polo-like kinases during the first wave of spermatogenesis                                                  
(A) mRNA expression for PLK1-4; syce1 was used as control for progression of the first 
wave of spermatogenesis; Actb was used as mRNA loading control                                                                            
(B) Protein expression for PLK1-4; syce1 was used as control for the progression of the 








Figure 7: Nuclear spreads showing localization patterns for PLK1-4 during pachytene and 
diplotene stages of meiotic prophase respectively. (Jordan et al., 2012) 
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PLK4 AND THE CENTROSOME 
 Centrosomes are the major microtubule organizing center (MTOC) of animal cells 
and their accurate number is critical to genome integrity. Centrosomes comprise of a 
pair of centrioles arranged orthogonally and centriole duplication controls centrosome 
duplication which occurs once per cell cycle. As mentioned earlier PLK1, PLK2 and PLK4 
localize to the centrosomes and although PLK1 and PLK2 are involved in regulating 
centriole duplication, centrioles that are MTOC competent (referring to the ability of 
centrioles to recruit pericentriolar materials and nucleate microtubules) when 
disengaged from daughter centrioles can support duplication irrespective of whether 
PLK1 is present or not (Wang et al., 2011). Plk2-knockout mice are also viable, 
suggesting that its function can be substituted by other polo-like kinases (Ma et al., 
2003). PLK4 on the other hand associates with the centrioles throughout the cell cycle. 
Its overexpression as shown in various studies leads to increased centriole numbers and 
its depletion causes progressive reduction in centriole numbers (Habedanck et al., 
2005). Hence, PLK4 is key to the process of centriole formation and has been termed the 
master regulator of centriole biogenesis. PLK4 is indispensable to cells as indicated by its 
presence in actively dividing tissues and PLK4 knockout embryos arrest at stage E7.5 
(Hudson et al., 2001).Research on PLK4 has focused on its canonical centrosome 





PLK4: CONTROL AND REGULATION 
To ensure that centriole duplication does not go awry and to maintain genome 
integrity, PLK4 abundance in the cell must be tightly controlled and regulated. PLK4 is a 
low abundance kinase whose stability is directly linked to the activity of the enzyme, its 
expression is controlled transcriptionally with its mRNA expression increasing from 
interphase and reaching a peak during mitosis (Fode et al., 1996) and meiosis (Jordan et 
al., 2012). In mouse cells Plk4 mRNA levels are downregulated by the p53-DREAM 
signaling pathway. Nuclear factor-kB (NF-kB) has also been shown to activate PLK4 
expression (Ledoux et al., 2013). The PEST sequences also govern PLK4 protein stability 
(Figure 8). One PEST sequence is located within the amino terminus and two others 
within the carboxy terminus- all of which play a part in the turnover of the kinase 
(Yamashita et al., 2001). The first PEST sequence contains a degron motif, which is 
conserved all through evolution (Figure 8). Phosphorylation of the serine and threonine 
residues in the degron motif generates a binding site for the ubiquitin ligase SCF (SKP1-
CUL1-F-BOX) complex (Cunha-Ferreira et al., 2009). This SCF complex ubiquitinates PLK4 
and it is targeted to the proteasome for destruction (Rogers et al., 2009). 
Finally, PLK4 has a short half-life of about 2-3 hours in the cell (Fode et al., 1996). 
Several studies have shown that the kinase activity of PLK4 autoregulates its own 
stability. Inactivation of the kinase activity of PLK4 has been shown to stabilize the 
protein accumulating up to > 10 fold higher levels than the active kinase, suggesting that 
active PLK4 stimulates its own breakdown (Peel et al., 2012). The SCF E3 ubiquitin ligase 
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has been found to localize to the centrosomes associating with substrates 
phosphorylated at specific sites in phosphodegron motifs (Klebba et al., 2013). The 
speculated mechanism of PLK4 degradation by autophosphorylation is depicted in 
Figure 9. Two PLK4 monomers homodimerize through their CPB domains and the 
intertwining of PB3 domains, the kinase domain also becomes active through auto-
phosphorylation. This is followed by transphosphorylation of the degron which activates 
a negative feedback pathway promoting its degradation through the ubiquitin–
proteasome pathway (Jana et al., 2012; Sillibourne et al., 2010). The degron 
phosphorylation is dependent on autophosphorylation of sites around it (Holland et al., 
2010), however, this multisite trans-autophosphorylation around the degron ensures 
that the PLK4 protein phosphorylation attains threshold before its autodestruction 
(Cunha-Ferreira et al., 2013). This phosphorylation-dependent degradation of PLK4 is 
counteracted by protein phosphatase 2A (PP2A) which stabilizes PLK4 during mitosis 
(Brownlee et al., 2011). Worthy of note however is that PLK4, though reported to be a 
low abundance kinase is highly expressed during spermatogenesis and this suggests a 






Figure 8: The degron motif of PLK4 (highlighted in blue) conserved in various species; 
potential sites for autophosphorylation (highlighted in red); S305, conserved and 




Figure 9: Speculative model for PLK4 dimerization, tans-autophosphorylation of the 
degron motif, recognition of the phosphorylated degron motif by the SCF complex and 




PLK4 AND SPERMATOGENESIS 
 PLK4 research, though largely centered on its canonical role in centriole 
biogenesis, it has recently been implicated to have novel roles in spermatogenesis. In a 
screen for ENU-induced mutations that cause male hypogonadism, Harris et al, (2011) 
identified a novel heterozygous missense mutation in the kinase domain of PLK4, 
altering an isoleucine to asparagine at residue 242 (I242N). This study demonstrated 
that PLK4 is required for proficient spermatogenesis. Histologically, the affected animals 
show discrete regions of abnormal seminiferous tubules lacking in germ cells which they 
describe as patchy germ cell loss observed from postnatal day 10 and subsequent 
stages, their testis size was also reduced by 17%. In another study carried out by 
Miyamoto et al., (2015) where they carry out mutational analysis of 81 patients with 
azoospermia and sertoli cell-only syndrome (SCOS), they identified one man with a 13-
bp deletion in the Serine/Threonine kinase domain of PLK4 also implicating a possible 
role for the protein in spermatogenesis. Furthermore, our lab discovered that PLK4 
localized to at the sex body during pachynema and diplonema of meiotic prophase I and 
its localization pattern is similar to other proteins such as ATR, BRCA1 and γH2AX that 
are involved in DNA damage response (DDR) and meiotic sex chromosome activation 
(MSCI). However, a specific role for PLK4 in mammalian spermatogenesis is yet to be 
discovered. My project aims to assess the effects of inhibiting PLK4 on meiotic 
progression during the first wave of spermatogenesis in mammalian germ cells, using 
mice as a research model. 
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PLK4 AND MSCI  
 Having established that PLK4 localizes to the sex body during prophase I of 
meiosis, its localization pattern resembles other proteins such as ATR, BRCA1 and γH2AX 
that are involved in DNA damage response (DDR) and meiotic sex chromosome 
activation (MSCI). Defective synapsis is recognized by the pachytene checkpoint via DNA 
damage repair factors such as ATR and BRCA1, the homologs that fail to synapse are 
transcriptionally inactivated in a chromosome wide phosphorylation of H2AX (γH2AX) in 
a process known as meiotic silencing of unsynapsed chromosomes (MSUC). Persistent 
autosomal asynapsis is thought to trigger apoptosis by starving the cells of essential 
gene products (Royo et al., 2010, 2013). During male meiosis, neither sex chromosome 
has a homolog. However, the largely heterologous X and Y (sex) chromosomes do pair 
and synapse along a spatially restricted region called the pseudo-autosomal region 
(PAR) which is where recombination occurs. The unsynapsed region of the sex 
chromosomes undergoes remodeling of the chromatin into heterochromatin, leading to 
transcriptional inactivation and compartmentalization of the sex chromosomes into a 
specialized and visible domain called the sex body within the nucleus of pachytene-
staged spermatocytes. This process of transcriptionally silencing of the heterologous X 
and Y (sex) chromosomes during prophase I of male meiosis is called meiotic sex 
chromosome inactivation (MSCI) (Figure 10) and is thought to be a more complex 
manifestation of MSUC. Errors in chromosome synapsis have long been associated with 
chromosomal anomalies and infertility (Harton and Tempest, 2012). Sex chromosome 
abnormalities e.g. Klinefelter (XXY) syndrome constitutes the largest class of 
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chromosome abnormalities and the commonest genetic cause of infertility in humans, 
approximately one-half of such cases results from non-disjunction of X and Y homologs 
at the first meiotic division (Thomas and Hassold, 2003; Heard and Turner, 2011). The 
escape from MSCI is also thought to be directly responsible for pachytene arrest on XYY 
mice and men which leads to germ cell loss and eventual infertility (Turner et al., 2006; 
Mahadevaiah et al., 2000). MSCI failure therefore leads to apoptosis and the process is 
indispensable for male fertility (Royo et al., 2010, 2013). The mechanistic details and 
various players involved in MSCI are still yet to be fully elucidated and PLK4 may very 









Figure 10: An overview of MSCI. A- Pachytene spermatocytes stained for SYCP3 and 
γH2AX which marks the transcriptionally silenced domain (the sex body). B- At the 
beginning of zygotene BRCA1 and ATR are present at the sites of double stranded breaks 
(DSBs). At zygotene/pachytene transition there is further recruitment of BRCA1 and ATR 
which phosphorylates H2AX triggering changes leading to MSCI. C- Schematic of XY 
pachytene spermatocytes with three fully synapsed bivalents and the asynapsed region 





CURRENT PROJECT AND HYPOTHESIS 
 Having established the possibility of an active role of PLK4 in spermatogenesis, 
we hypothesize that inhibiting the kinase activity of PLK4 may lead to aberrant DNA 
repair process, chromosome missegregation, disruption in the meiotic process and 
eventual loss of germ cells. Due to the similarity of the kinase domains in PLK1-4, their 
sensitivities to small molecule inhibitors are similar. Kinase inhibitors such as MLN8054 
have been previously reported to target numerous kinases including PLK4 but with 
greater specificity for Aurora A and B (Karaman et al., 2008). Another inhibitor VX-680, a 
dual Aurora A/B inhibitor (Girdler et al., 2008) has also been shown to inhibit PLK4 with 
IC50 of <0.3µM in the presence of 100µM competing ATP (Sloane et al., 2010). 
Using VX-680 as a template to create a selective PLK4 inhibitor, Wong et al., 
(2015) introduced a methoxy substituent at the VX-680 C5 position and generated a 
compound with ~15-fold preference for PLK4 over Aurora A. Approximately 34% of the 
analogs they synthesized had half-maximal inhibitory concentration (IC50) values ≤ 
100nM for PLK4 in vitro. Only one of those analogs depleted centrosomes in NIH/3T3 
mouse embryonic fibroblasts at concentrations <10µM, this analog was optimized to 
produce two highly selective PLK4 inhibitors that were named - Centrinone (centrosome 
depletion at 100nM) and Centrinone B (centrosome depletion at 500nM). Both 
Centrinones were reported to exhibit >1000 selectivity for PLK4 over Aurora A/B in vitro 
and did not affect cellular Aurora A or B.  
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To show the selectivity of Centrinone for PLK4 over Aurora A and B, they treated HeLa 
cells with DMSO, VX-680 (1µM) and Centrinone (125nM) for 7 hours and then treated 
with reporters of Aurora A and B activity. The results show same phenotype for 
Centrinone and DMSO with the expected inhibitory effect from VX-680. Finally, shown 
below are two tables reflecting the binding affinity of Centrinone for PLK4 and other 
kinases. 
Table 1 - Ki values of centrinone, centrinone B and VX-680 for PLK4 and                                                                                       
Aurora A/B 
KINASES                                   Ki (nM) 
Centrinone Centrinone-B VX-680 
PLK4 0.16 0.59 7.66 
AURORA A 171.00 1239.00 0.65 
AURORA B 436.76 5597.14 3.36 
 
 Table 2 - Ki values of centrinone, centrinone B and VX-680 for PLK4 and other kinases 
KINASES                                         KI(nM) 
 Centrinone  Centrinone-B 
PLK4 0.16 0.59 
TNK1 1.38 6.04 
LRRK2 2.08 7.66 
ROS/ROS1 2.77 90.07 
FLT4/VEGFR3 6.29 58.04 
RET 13.92 195.25 
JAK2 >150 >500 




Thus far, PLK4 has only been studied within the context of its centrosome 
function with no information about its role in spermatogenesis. As previously stated, 
mutation in the kinase domain of PLK4 has been associated with germ cell loss and PLK4 
localizes to the sex body during meiotic prophase I (Harris et al., 2011; Jordan et al., 
2012), and so we hypothesize that PLK4 is required for chromosomal segregation and 
the normal progression of MSCI and inhibiting PLK4 will lead to abnormalities in meiotic 
progression. To test this hypothesis, we extract pachytene-staged spermatocytes from 
mice at 17-19 dpp which are undergoing first wave of spermatogenesis, the cells are 
cultured in spermatocyte culture media before the addition of centrinone, the small 
molecule reversible inhibitor of PLK4. We assess meiotic progression, chromosome 
synapsis, sex body formation, DNA damage and its response proteins while inhibiting 
PLK4. Further analyses were done on the ENU mice carrying a heterozygous mutation 
for PLK4 (Plk4+/I242N). We report that PLK4 indeed localizes to the sex body during 
meiotic prophase I, centrinone specifically inhibits PLK4, delayed meiotic progression 
and we show evidence of a DNA damage response observed while inhibiting PLK4. We 
also report that RNA Polymerase II (RNA Pol II) which is normally excluded from the sex 
body indicating normal MSCI is not robustly excluded in the mutant. These findings 
provide and promote the evidence that PLK4 is required to ensure accurate 





MATERIALS AND METHODS 
ENU MUTAGENESIS 
Plk4+/I242N mice were generated by administering the chemical mutagen N-
nitroso-N-ethylurea (ENU) to mice via intraperitoneal injection as described by Siekpa 
and Takahashi, 2005. Mutagenesis was performed on male mice of the C57BL/6J (B6) 
strain, ENU-treated males (G0 generation) were allowed 12 weeks to recover fertility 
and were then crosses to untreated B6 females yielding G1 generation males and 
females. For the cross designed to detect dominant mutants, G1 males and females 
were bred to wild type DBA mice and the resulting F1 male progeny screened. For the 
cross designed to detect recessive mutants, G1 males were bred to wild type B6 females 
and the resulting G2 females were back-crossed to their G1 fathers yielding G3 male 
pprogeny for screening. Mice were monitored and screened for urogenital morphology, 
testis weight measurement and testicular histology. Mice were killed at postnatal (P) 1, 
P10, P15, P21, P31, and 6 and 8 weeks of age, testis and body weights were recorded for 
all postnatal animals and photographs of the testes of wild type and mutants were 
taken at 6 weeks. All experiments were conducted in accordance with the National 






POLYMERASE CHAIN REACTION (PCR), PCR CLEANUP AND SEQUENCING 
 Genotyping of wild type and mutant mice was done by PCR. DNA was extracted 
from mice by digesting tail tips first with 50 mM NaOH, followed by centrifugation and 
boiling to completely dissociate the tissue. This is then neutralized with 1M tris HCl         
(pH 8) and serves as DNA template for the PCR reaction. Each PCR reaction contained a 
total volume of 50µl, consisting of molecular grade water, 10x buffer, dNTPs, DNA 
polymerase, primers and DNA from sample (Table 3). The following PCR conditions were 
used: 
1. Denaturation: 900C for 1 minute 
2. Denaturation: 900C for 20 seconds 
3. Annealing: 580C for 30 seconds 
4. Amplification: 720C for 1 minute 
5. Steps 2-4 were repeated for 30 cycles 
6. Final extension: 720C for 10 minutes 
  After PCR completion, 10 µl of each sample was run on a 2% agarose gel to check 
if the PCR worked before proceeding to a PCR cleanup. Cleanup was done using the 
isolate II PCR and gel kit (Bioline) containing binding buffer, wash buffer and elution 
buffer. Finally, 10 µl of each cleaned up PCR reaction is added to 5 µl of the primer 
sequence -CGAAGTGCACATGGACTTGAAT- and sent for sequencing. The sequence 
ACCTTAT indicates the wild type sequence while ACCTTAT/A indicates the heterozygous 
mutant sequence (Figure 11).  
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Table 3: PCR setup for 4 samples 
REACTION VOLUME/REACTION (µl) MASTER MIX VOL (µl) 
H20                               38.2                               152.8 
10x buffer                                 5                                 20 
DNTPs                                 0.4                                   1.6 
DNA polymerase                                 0.4                                   1.6 
Primer mix 471 + 474                                 1                                   8 
Total                                 184 
Master mix per sample                                   46 
DNA per sample                                      4 
 
 
Figure 11: The sequence of the wild type (Plk4+/+) shown above and the ENU 




GERM CELL EXTRACTION AND MICROSPREADS 
 Germ cells were isolated from mice at 17-19 days post-partum (dpp) which are 
enriched in mid-prophase spermatocytes (2.5 x 106 cells/ml). Mice were euthanized via 
cervical dislocation, and both testes were removed and placed in 1x phosphate buffered 
saline (PBS). The tunica albicans was then removed and detunicated testes placed in 
Krebs-Ringer bicarbonate solution (KRB) supplemented with protease inhibitor (PI) 
cocktail solution (Roche) to prevent degradation of proteins and liberate germ cells. The 
testes is shredded using fine forceps and solution allowed to sit in 5ml KRB for a few 
minutes, then filtered using 0.8µm Nitex mesh and allowed to centrifuge at 2500 rpm 
for 7 minutes at 40C. The supernatant is discarded, the cells resuspended with 
spermatocyte culture media and left to equilibrate for 1-2 hours in the incubator (320C) 
before the addition of inhibitors. To inhibit PLK4, 5µM centrinone was used; 5µM 
ZM447439 was used to inhibit Aurora kinases, 5µM okadaic acid (OA) was used to 
induce prophase to metaphase (G2/MI) transition. DMSO and ethanol were used as 
control.  
Cells are collected at the various time points set for each experiment, 
centrifuged at 9000rpm for 5 minutes, supernatant discarded, cells resuspended with 
0.1M sucrose solution, and placed on slides incubated with 1% PFA solution. Slides were 
allowed to sit for 2-2.5 hours in a dark moist chamber, rinsed in 1x PBS + 0.2% photoflo 
solution, left to air dry and then washed 3x in wash buffer (1x PBS with Antibody 
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Dilution Buffer [ADB]) before the addition of primary antibodies. Solution compositions 
are shown below (Table 3). 
 
STAINING AND MICROSCOPY 
 Primary antibodies were placed on slides and left to incubate at 40C overnight. 
Primary antibodies against the following proteins were used: Goat anti-SYCP3 (1:50 
dilution), Rabbit anti-PLK4 (1:200 dilution), Rabbit anti-SYCP1 (1:1000 dilution), Mouse 
anti-RNA Pol II (1:400 dilution), Mouse anti-γH2AX (1:400 dilution), Goat anti-ATR (1:50 
dilution), Rabbit anti-RAD 51 (1:100 dilution). After incubating with primary antibodies, 
slides are rewashed in 1x PBS + photoflo and wash buffer steps repeated in preparation 
for secondary antibodies. These primary antibodies were detected with secondary 
antibodies raised against mouse, rabbit and goat and conjugated to Alexa 488, 555 and 
647 (life technologies) at 1:500 dilution and then left to incubate for 1-2 hours in the 
dark moist chamber at 370C.                                                                                                                                                                
 After incubation with secondary antibodies, slides are washed 2x in 1x PBS + 
0.2% photoflo and 2x in water + 0.2% photoflo (pH 8.0). Spreads are then mounted with 
Vectashield + DAPI medium (Vector Laboratories) and images captured using an Axio 






Tissues from the testis was fixed in bouins fixative then washed in 70%, 90% and 100% 
ethanol to dehydrate the tissue. Tissues were then embedded in paraffin and serial 
sections 5 microns thick (5µm) were placed onto slides and stained with hematoxylin 
and eosin (H&E).  
 
IMAGE AND STATISTICAL ANALYSIS 
 Images were processed and analyzed using the Zeiss Zen 2012 blue edition 
image software. Further analysis was completed using Adobe Photoshop CS6 and the 
Image J software provided by the National Institute of Health. Data was then exported 










TABLE 4 – SOLUTIONS 
SOLUTION INGREDIENTS 
Krebs-Ringer Bicarbonate Media  39.0ml of 9% NaCl 
 15.6ml of 1.15% KCl 
 16.3ml of 6.5% NaHCO3 
 3.9 ml of 2.1% KH2PO4 
 3.9ml of 3.8% MgSO4 .7H2O 
 5.9ml of 1.2% CaCl2 
 5.0ml of 100x 
Penicillin/Streptomycin/Glutamine 
 5.0ml of 100x non-essential aa 
 50x MEM essential aa 
Spermatocyte Culture Media  50ml MEMα 
 145µl Na lactate 
 2.5ml FBS 
 0.295g Hepes 
Sucrose (0.1M), 5ml  1ml of 0.5M Sucrose 
 4ml o MQ H20 
 100µl of 50mM NaOH (to bring the 
pH to 8) 
 20µl of 50x protease inhibitor 
cocktail (Roche) 
PFA (1%), 5ml  312.5µl of 16% PFA 
 4687.5 MQ H20 
 60µl of 50mM NaOH (to bring the pH 
to 8) 
 20µl of 50x protease inhibitor 
cocktail (Roche) 
 50µl of 10% Triton X-100 
Antibody dilution buffer (ADB)  50ml of PBS 
 3% BSA 
 10% goat or horse serum 
 0.05% Triton X-100 
Washing/Blocking buffer (WB) (10% 
ADB) 
 45ml of PBS 







PLK4 SIGNAL LOCALIZES TO THE SEX BODY DURING PACHYNEMA AND 
DIPLONEMA 
 The localization of PLK4 to during meiosis prophase I as reported previously was 
confirmed by chromosome spread preparations (Figure 12). PLK4 localizes to the largely 
unsynapsed X and Y chromosome pair during prophase I of male meiosis resembling the 
localization of other protein known to be involved in MSCI such as ATR, DMC1 and 
γH2AX (the phosphorylated form of H2AX and also a marker for meiotic double strand 
breaks). PLK4 has also been observed to localize at unsynapsed autosomal axes in wild 
type and abnormal cells bearing Robertsonian translocations (data not shown). Using 
antibodies against the lateral element protein of the synaptonemal complex SYCP3 as a 
marker to stage the progression of meiosis, wild type mice at 17-20 days post-partum 
(dpp) are usually enriched in pachytene and diplotene stage cells. At pachynema, all 
autosomes are fully synapsed as indicated by linear SYCP3 signal while the X and Y 
chromosomes are synapsed only at the pseudoautosomal region (PAR) and have 
compartmentalized to form the sex body. At diplonemaa, desynapsis has begun and this 
is marked by disassembly of the SC central elements, the sex chromosomes however 
remain compartmentalized in the sex body domain. PLK4 signal is shown at the sex body 
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Figure 12: Localization of PLK4 in the male germ cell. Chromosome spreads from 
primary spermatocytes of B6 wild type mice aged 18 dpp were immunolabeled using 
antibodies against SC lateral element protein SYCP3 (red), PLK4 (green), γH2AX (far-red). 

















OPTIMIZATION OF CENTRINONE TO MAXIMALLY INHIBIT PLK4 
 Wong et al., (2015) developed the small molecule inhibitor, centrinone to 
selectively inhibit PLK4 and reversibly deplete centrioles from cells. The authors used 
125nM and 300nM concentrations of centrinone to inhibit PLK4 in various cell lines 
including HeLa and NIH/3T3. To determine the optimal concentration of centrinone to 
use for the male mouse primary spermatocytes, a time course experiment was carried 
out using different concentrations of centrinone for various times. Having mentioned 
that PLK4 is expressed at high levels during spermatogenesis, higher concentrations 
than were necessary to deplete centrioles in cell lines were tested. Concentrations 
tested were 500nM, 1µM, 1.25µM, 2.5µM, 5µM, 10µM and 20µM for 6 hours, 12 hours 
and overnight (20 hours) respectively.  Cells were assessed based on the quality of the 
spread and number of cells with γH2AX signal present throughout the chromatin (Figure 
13). Cells treated with 10µM and 20µM showed very low quality spreads and so 
treatment with 5µM centrinone for 20 hours was chosen for the experiments (Figure 
14). To further prove the specificity of centrinone for PLK4 and not Aurora kinases, 
experiments were done comparing the effect of centrinone and ZM447439 (Aurora 
kinase inhibitor) during meiotic prophase I. The results demonstrated that cells treated 
with ZM447439 did not display the widespread localization of γH2AX typically seen with 
centrinone treatment (Figure 15A). Furthermore, with the addition of okadaic acid, a 
phosphatase inhibitor known to induce the prophase to metaphase transition, cells 
treated with ZM447439 arrest at diplotene while centrinone treated cells progress 
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Figure 13: γH2AX signal located on the sex body of wild type cells and present 









































Figure 14: Time course experiments with different concentrations of centrinone at 
various time points to choose an optimal effective concentration of centrinone for the 
male mouse primary spermatocytes. Assessment of cells after 6 hours of inhibition with 
centrinone show the normal phenotype similar to the wild type cells, 12 hours inhibition 
show a mix of normal and abnormal cells and at 20 hours all cells at 10µM and 20µM 
are abnormal. Cells were treated with 5µM centrinone for 20 hours. 
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Figure 15A: Delineating the effects of centrinone from other kinase inhibitors, 
treatment with centrinone shows widespread γH2AX signal but γH2AX signal is limited 
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Figure 15B: Delineating the effects of centrinone from other kinase inhibitors, addition 
of okadaic acid initiates exit from meiotic prophase as indicated by the disassembly of 
lateral element protein SYCP3. At 3 hours all cells are at diplotene stage, ZM447439 
treated cells arrest at this stage while centrinone and wild type progress further. The 
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PLK4 INHIBITION WITH CENTRINONE SHOWS DNA DAMAGE PHENOTYPE 
 The phosphorylation of H2AX to form γH2AX is one of the earliest cellular 
responses to the formation of double strand breaks initiated by the meiosis specific 
topoisomerase II-like enzyme, SPO11 (sporulation 11) during leptonema of meiotic 
prophase I. As meiosis progresses, the loss of γH2AX occurs in conjunction with synapsis 
and at pachytene, γH2AX signal is completely absent at the autosomes and present only 
at the sex body (Mahadevaiah et al., 2001). We assessed pachytene stage cells after the 
addition of 5µM centrinone overnight using immunofluorescence microscopy and we 
observed several meiotic aberrancies. Most prominent was the spread of γH2AX signal 
present throughout the chromatin in ~ 80% of the cells. To confirm that this was due to 
the inhibition of PLK4 and not toxicity from centrinone, washout experiments were 
carried out by replacing centrinone treated media with fresh spermatocyte media 3x for 
3 hours respectively and all these cells show similar phenotype to the wild type cells 
(Figure 16A). Furthermore, we asked if the γH2AX signal was due to the presence of new 
double strand breaks and used antibodies to Radiation sensitive 51 (RAD51), a strand 
invasion protein to assess that. RAD51 foci was clearly seen on both autosomes and sex 
chromosomes in about 20% of the cells at pachytene stage indicating a possible new 
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Figure 16A: γH2AX signal at the sex body of normal cells and all washout cells but all 
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                                                                       Figure 16B: RAD51 foci at the sex body of normal  
                                                                  cells but all over the chromosomes of cenntrinone  
                                                                  treated cells (pachytene and diplotene stages) 
                                                                  N=200 per experiment and each experiment was  
                                                                  Done at least thrice, scale bars: 10µm   
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PRELIMINARY DATA FROM ENU MICE 
 Harris et al., 2011 carried out a genome-wide mutagenesis using N-ethyl-N-
nitrosurea (ENU) in male mice to identify genes potentially involved in spermatogenesis 
and male infertility. ENU introduces single nucleotide mutations which typically result in 
missense mutations (Justice et al., 1999), the resulting mutagenized mice identified 12 
candidate genes using a SNP panel. On further sequencing of the exons and exon-intron 
boundaries, no mutations were identified except in Plk4.The amino terminal 
Serine/threonine kinase domain of Plk4 (residues 12-265) in mice and man, contains the 
catalytic active site of the protein. The authors identified a novel heterozygous missense 
mutation in this domain of Plk4, altering an isoleucine to asparagine at residue 242 
(I242N) (Figure 17). The homozygous Plk4I242N/I242N mutation is embryonically lethal and 
so all analyses were performed using the heterozygous Plk4+/I242N mice. Heterozygous 
Plk4+/I242N mice showed a reduction in testis to body weight ratio with affected animals 
reduced by 17.5% compared with the wild type littermates at 6 weeks of age (Figure 
18). Testis histology was normal at postnatal day 1 (P1) but germ cell loss was detected 
at P10 and subsequently. The defective tubules were identified to contain only sertoli 
cells. 
 
Figure 17: Schematic of the functional domains of PLK4 and identification of the ENU-
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Figure 18: Phenotypic features of ENU mutant. (A) Quantification of testis weights at 6 
weeks of age (B) Gross examination of whole testes at 6 weeks of age (C) Histological 
sections of wild type (Plk4+/+) and mutant (Plk4+/I242N) at postnatal day 21. Asterisks in 







PROPHASE I DEFECTS IN ENU MICE 
 We assessed the localization of RNA polymerase II (RNA pol II) in wild type and 
ENU mice. RNA pol II is a marker of transcriptional activity which is normally absent at 
the sex body during pachynema and diplonema to indicate transcriptional silencing in 
wild type mice. The heterozygous Plk4+/I242N mutant fails to completely exclude RNA pol 
II at the sex body suggesting that PLK4 influences transcriptional activity and therefore 
meiotic silencing. The quantification of the fluorescence intensity of the RNA pol II signal 
at the sex body compared to the total chromatin in both wild type and mutant showed a 
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Figure 19: A) RNA Pol II localization in wild type (Plk4+/+) and mutant (Plk4+/I242N) shown 
for pachytene and diplotene stage cells, white arrowheads point to the position of the 
sex body. Scale bars: 10µm B) quantification shown below, N=48 for each genotype, 
error bars represent mean + SEM, Statistical analysis was done using Mann-Whitney test 
showing slight significance (*) with P = 0.0470. 
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HISTOLOGICAL DEFECTS IN ENU MICE 
 We also assessed the seminiferous tubules from wild type (Plk4+/+) and ENU 
heterozygous mutant (Plk4+/I242N) from 14 dpp to 20 dpp to examine for defects and 
germ cell loss as observed by Harris et al., 2012. As cells progress through 
spermatogenesis, the seminiferous tubules are lined by a complex stratified epithelium 
containing two distinct populations of cells- spermatogenic cells which will eventually 
form spermatozoa and sertoli cells which are the epithelial cells that surround the germ 
cells providing nutrients for them as well as phagocytosing excess spermatid cytoplasm. 
Spermatogonia are the first set of spermatogenic cells always located in contact with 
the basal lamina of the seminiferous tubules, they give rise to primary spermatocytes 
which undergo the first meiotic division and secondary spermatocytes which undergo 
the second meiotic division, these eventually form spermatids seen in the luminal part 
of the tubules. ENU heterozygous mutants (Plk4+/I242N) clearly show defective tubules as 
compared to the corresponding wild type (Plk4+/+) of each stage. Shown below at 
various magnifications is the cross section of whole testis (dpp 16) of wild type (Plk4+/+) 
which is seen as very compact with spermatogonia and primary spermatocytes. In 
contrast, the mutant (Plk4+/I242N) cross sections display loss of primary spermatocytes 
(Figure 20). This is followed by quantification of the number of cells in seminiferous 
tubules of wild type (Plk4+/+) and mutant (Plk4+/I242N), the area of the seminiferous 
tubules of wild type (Plk4+/+) and mutant (Plk4+/I242N) and the ratio of the number of cells 
per tubule to the area of the tubule for wild type (Plk4+/+) and mutant (Plk4+/I242N). Each 
quantification shows a significant difference for the wild type versus the mutant.  
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Figure 20: Histologic cross section of whole testis of wild type (Plk4+/+) and mutant 
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Figure 20 cont: Histologic cross section of whole testis of wild type (Plk4+/+) and mutant 
(Plk4+/I242N) - C) x40 magnification D) various quantification measures of seminiferous 
tubules in wild type (Plk4+/+) and mutant (Plk4+/I242N). N=40 for each genotype, error bars 
represent mean + SEM, Statistical analysis was done using Mann-Whitney test showing 
extreme significance (***) with P < 0.0001 in each case. 













































































 So far the role of PLK4 has been established in centriole biogenesis. However, a 
mutation in its kinase domain resulting in hypogonadism and patchy germ cell loss 
(Harris et al., 2011) as well as previous findings in our lab provide the premise for a 
novel function for PLK4 during spermatogenesis. The goal of this study was to further 
our knowledge on the role of the protein PLK4 in spermatogenesis by assessing the 
progression of meiosis while inhibiting its action and also in the heterozygous Plk4+/I242N 
mutant. In addition to polo-like kinases, other kinases such as cyclin-dependent kinases 
(CDKs) and Aurora kinases as well as phosphatases are key regulators of cell cycle 
events. Previous studies have successfully used small molecule inhibitor analyses to 
indicate their various roles during spermatogenesis. 
The prophase to metaphase I (G2/MI) transition can be artificially stimulated by 
addition of the phosphatase inhibitor, okadaic acid (OA) (Wiltshire et al., 1995). The 
signature event of the G2/MI transition is the disassembly of the SC followed by 
chromatin condensation and compaction of the MI bivalent chromosomes. Sun and 
Handel, 2008 studied the enzymatic control of these events using the small molecule 
inhibitors- butyrolactone I (BLI), an inhibitor of cyclin dependent kinases (CDKs) and 
ZM447439 (ZM), an inhibitor of Aurora kinases and show that neither BLI nor ZM 
inhibited disassembly of the central element of the SC. The central element of the SC, 
SYCP1 bridges the two lateral elements of the SC and is essential for synapsis as synapsis 
does not occur in mice lacking SYCP1 (de Vries et al., 2005). The SC disassembles as 
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meiotic cells progress from pachynema through diplonema. The hallmark of this exit is 
desynapsis and it is marked by the removal of the central element of the SC, SYCP1 
(Moens, 1995). G2/MI transition is predominantly controlled by the metaphase 
promoting factor (MPF) which consist of cyclin subunits as well as other candidate 
kinases including the Aurora kinases (Carmena and Earnshaw, 2003).  Taking advantage 
of the experimental induction of the G2/MI transition with OA, together with the 
addition of the small molecule inhibitors, Sun and Handel, 2008 show that desynapsis 
and removal of SYCP1 began rapidly after treatment with OA or OA + BLI. Thus 
desynapsis is not sensitive to the CDK inhibitor BLI. Also, the OA-induced disassembly of 
SYCP1 was not affected by ZM as spermatocytes treated with either OA or OA + ZM 
completed desynapsis within 3 hours. The authors therefore use inhibitor analysis to 
reveal that CDKs and Aurora kinases are not involved in the disassembly of the SC 
central element. In a subsequent inhibitor analysis study using the potent and small 
molecule inhibitor of mammalian PLK1, BI 2536 optimized by Steegmaier et al., 2007 
and OA to also induce G2/MI transition, Jordan et al., 2012 show that inhibiting PLK1 
inhibited the OA –induced dissassebly of the SC central and lateral elements.                                                                                                                                                                                                             
 Cyclin-dependent kinase 2 (CDK2) is known to play important roles in 
mammalian cell cycle progression, both at the transition from G1 to S and through S 
phase. Cdk2-/- spermatocytes show incomplete chromosome pairing and formation of 
sex body, an extensive non-homologous synapsis and an arrest at pachytene-like stage 
with unrepaired programmed double-strand breaks (Viera et al., 2009). Phosphorylation 
of CDK2 at threonine 160 (p-CDK2) is essential for its kinase activity and has been 
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implicated as a potential regulator for MSCI in male mice (Wang et al., 2014). 
Mevastatin, an inhibitor of cholesterol synthesis, inhibits cell growth by inhibiting CDK2 
(Ukomadu and Dutta, 2003). Wang et al., (2014) treated pachytene stage spermatocytes 
with mevastatin and they report an absence of p-CDK2 at the sex body which is normally 
not the case in non-inhibited cells. They also notice an upregulation of sex chromosome 
genes as well as RNA Polymerase II staining visible on the sex chromosome in 
mevastatin-treated spermatocytes therefore suggesting a role for p-CDK2 in the 
transcriptional activity of sex chromosome genes and also in MSCI. Inhibition of CDK2 
has also been shown to block centrosome duplication (Matsumoto et al., 1999; Lacey et 
al., 1999). Overexpression of PLK4 cannot cause centrosome amplification in the 
absence of CDK2 activity, conversely, CDK2 activity cannot cause centrosome 
amplification in the absence of PLK4 activity clearly indicating that both proteins 
cooperate to control centrosome duplication (Habedanck et al., 2005). 
The data reported here confirm the localization of PLK4 to the sex body during 
pachynema and diplonema of meiotic prophase I. Colocalization of PLK4 with γH2AX 
during pachytene suggest that PLK4 possesses a novel role in DNA repair and MSCI. By 
treating the primary spermatocytes of wild type mice with centrinone, a PLK4 inhibitor, 
we observe delayed meiotic progression but not meiotic arrest. We also observe a 
widespread localization of γH2AX throughout the chromatin of centrinone treated cells. 
This phenotype suggests either delayed DDR or the presence of new DNA damage and is 
confirmed by the presence of RAD51 foci on the chromosomes of pachytene stage cells. 
To rule out the possibility of the DNA damage resulting from toxicity of centrinone 
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rather than PLK4 inhibition, washout experiments were carried out and the retrieved 
cells showed phenotype similar to the wild type cells confirming the inhibition was 
causative for the observed phenotype. However, because γH2AX may also be a signal 
for apoptosis in cells, use of other apoptosis markers such as cleaved caspase-3 or 
cleaved poly (ADP) ribose polymerase will be necessary to confirm if the cells are dying 
in response to centrinone treatment. 
 Due to the embryonic lethality of the homozygous Plk4I242N/I242N mice, the I242N 
mutation can only be studied in the heterozygous state. This mutation in PLK4 results in 
a change from isoleucine to asparagine at amino acid 242, because isoleucine is an 
aliphatic, hydrophobic amino acid whereas asparagine is polar and hydrophilic, it is likely 
that this substitution results in a conformational change in the kinase domain of PLK4 
(Harris et al., 2011). PLK4 mutation in other organisms has been studied. Drosophila 
melanogaster PLK4 mutants lose their centrioles during the mitotic divisions preceding 
male meiosis but still produce the same number of primary spermatocyte cysts as the 
wild type, the spermatids however lack centrioles and are unable to produce axonemes 
(bundle of microtubules that form the core of the sperm flagellum and are responsible 
for movement) (Bettencourt-Dias et al., 2005). When the C terminus of the PLK4 
homolog in Caenorhabditis elegans is truncated, there is decreased mitotic centriole 
duplication and centrosome amplification in the meiotic cycle (Peters et al., 2010). 
Interestingly, various studies have reported cross talks between the centrosomes, DNA 
repair and infertility. DNA damage response and repair proteins such as BRCA1 and 
ATM/ATR kinases localize to the centrosome, ATR is one of the proteins responsible for 
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Seckel syndrome, an autosomal recessive disorder characterized by intrauterine growth 
retardation, severe proportionate short stature and microcephaly (Rauch et al., 2008). 
ATR is also known to be involved in DNA damage response and its knockdown by siRNA 
leads to centrosome overduplication (Collis et al., 2008). BRCA1 is also involved in DNA 
repair and its knockdown leads to centrosome overduplication as well (Ko et al., 2006). 
The dysfunction of these proteins are known to cause tumorigenesis due to defective 
maintenance of centrosomes as well as impaired DNA repair (Shimada and Komatsu, 
2009). In another study investigating the contribution of the PBD of Cdc5 (yeast polo-
like kinase) in DNA damage response, the authors show that the PBD of Cdc5 is essential 
to mediate adaptation to persistent DNA damage and acts by targeting Cdc5 kinase 
activity to the yeast centrosome (Ratsima et al., 2016). Furthermore, the centrosomal 
protein CEP63 has been identified as a target for DDR kinases ATM and ATR in mitosis 
(Smith et al., 2009). Cep63 deficient cells and tissues do not show obvious defects in 
DNA damage signaling but exhibit impaired centriole duplication. Moreover, Cep63 
deficient mice are infertile exhibiting severe defects in meiotic recombination and a 
complete block in the generation of sperm (Marjanovic et al., 2015). The authors use 
SYCP3 and SYCP1 markers and show increased leptotene and zygotene stage cells in the 
mutant compared to the wild type, similar numbers of pachytene cells but very few cells 
(4%) progressed to diplotene stage suggesting progressive cell loss during prophase I. 
There was also increased number of RAD 51 and DMC1 foci observed from leptotene to 
zygotene in Cep63 mutants indicating that the formation of DSBs was not defective, 
however, their repair was defective as many pachytene and diplotene stage cells 
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exhibited diffuse γH2AX staining not confined to the sex body consistent with delayed 
repair. The mechanisms underlying the contribution of polo-like kinases to DNA damage 
response-particularly to the adaptation to persistent DNA damage still remain elusive 
(Archambault et al., 2015).   
We assessed the histology of seminiferous tubules from wild type and 
heterozygous Plk4+/I242N   mutant from 14-18 dpp. While the wild type tubules are tightly 
packed with germ cells, the Plk4+/I242N mutant appears morphologically abnormal with 
most tubules exhibiting more spacious lumen as well as loss of germ cells. Furthermore, 
RNA Polymerase II signal was not robustly excluded on the sex chromosomes of 
Plk4+/I242N as seen in wild type, suggesting ongoing transcription at the sex body which 
can be confirmed by real-time quantitative PCR and assessment of sex-linked genes for 
upregulated activity. Taken together, these data provide evidence for the role of PLK4 in 
spermatogenesis and more specifically, we have shown evidence that PLK4 is required 
for efficient DNA damage response and repair processes that are essential for meiotic 
progression. Our future work will define the mechanistic roles of PLK4 both within the 
nucleus and at the centromeres during spermatogenesis. Based on recent evidence, it is 
likely that these roles are inter-dependent. 
 In summary, various studies have shown an increasing number of proteins being 
found to localize at the sex body and taking part in the process of MSCI, their functions 
and mechanistic details are yet to be fully elucidated. We propose PLK4 as another 
major player and regulator of MSCI in male mice, further studies are however required 
to completely elucidate its involvement and mechanism. Future directions to fully 
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understand the role of PLK4 in spermatogenesis include: studying the mechanism of 
PLK4 recruitment to the chromosome axes and its possible substrates, further 
assessment of DNA damage/repair in the absence of PLK4, assessment of centriole 
function while inhibiting PLK4, assessment of the expression of sex-linked genes in wild 
type versus Plk4 mutant primary spermatocytes, and finally generating a conditional 















PUBLIC HEALTH SIGNIFICANCE 
 Polo-like kinase 4 (PLK4) is known to be the master regulator of centriole 
biogenesis. Centriole duplication is tightly controlled in the cell such that each cell has 
precisely two centrosomes, supernumerary centrosomes have been postulated to 
contribute to tumorigenesis and are prevalent in cancer (Firat-karalar and Stearns, 2014; 
Godinho and Pellman, 2014). Previous studies established that knockdown of the 
tumour suppressor p53 led to centrosome amplification in mouse fibroblasts and skin 
tumours (Fukasawa, 2007), further studies have also established that centrosome 
abnormalities are common in a variety of human tumours such as breast, prostate, lung, 
cancer and the brain (Lingle et al., 1998; Pihan et al., 1998).  
Various gene mutations including overexpression of Plk4 have also been linked 
with primary recessive microcephaly (MCPH), a neuro-developmental disorder 
characterized by a reduction in brain size during fetal development (Marthiens et al., 
2013). Most of the causative genes for microcephaly are linked to disruption in 
centrosome integrity. In a short medical report following the imaging and laboratory 
phenotyping of a consanguineous Saudi Arabian family in which two full siblings and one 
half sibling presented with classical features of Seckel syndrome, the phenotype was 
mapped to a single novel locus in which they identified a five base pair deletion in Plk4 
with schematic shown below (Shaheen et al., 2014) (Figure 21). Recent evidence also 
suggests a complex interaction between PLK4 and CEP152 centrosomal protein to form 
a scaffold upon which mature centrioles form and in the absence of PLK4, this step fails 
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(Kim et al., 2013). Cep152 has also been shown to be mutated in patients with Seckel 
syndrome (Kalay et al., 2011). Furthermore, CEP152 interacts with another centrosomal 
protein, CEP63 and are dependent on one another for centrosomal localization (Brown 
et al., 2013). Mice lacking the expression of Cep63 recapitulates the pathological 
outcomes reported in human patients with Cep63 mutations including growth defects 
and microcephaly (Sir et al., 2011; Marjanovic et al., 2015).  Having established the role 
of PLK4 in the centrosomes and the various diseases associated, also relevant is its role 
in spermatogenesis and fertility. 
Infertility has been classified as a disease by the American Society for 
Reproductive Medicine, stating also that the male partner is usually the sole cause or a 
contributor in 40% of cases. World Health Organization reports that one in every four 
couples in developing countries is affected and on a global scale, infertility is said to 
affect 15% of couples amounting to 48.5 million couples with males being solely 
responsible for 20-30% of these cases (Agarwal et al., 2015). Errors in chromosomal 
segregation during meiosis is associated with aneuploidy. Aneuploidy is the condition of 
having less than (monosomy) or more than (polysomy) the normal diploid number of 
chromosomes. Klinefelter syndrome (47 XXY) for example, is the most pervasive sex 
chromosomal anomaly affecting approximately 1:600 males and leading to 
hypogonadism and infertility (Nielsen and Wohlert, 1990). Turner syndrome (45, X) is 
also another frequent chromosomal abnormality caused by a missing or incomplete X 
chromosome. It is found in more than 7% of all spontaneous abortions and only 2% of 
the embryos survive to term. People with Turner syndrome develop as females and it is 
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typically caused by non-disjunction of the sex chromosomes during the formation of a 
sperm (or egg). 80% of Turner syndrome cases are the result of paternal non-disjunction 
resulting when sperm with no X chromosome unites with an egg to form an embryo 
with just one chromosome rather than two (Martinez-Pasarell et al., 1999; Tissot and 
Kaufman, Human Genetics). 
Harris et al., 2011 while trying to identify candidate genes potentially involved in 
spermatogenesis and male fertility carried out a genome-wide mutagenesis in mice and 
discovered Plk4 as a novel gene implicated in hypogonadism and patchy germ cell loss. 
Male mice with point mutation in the Plk4 gene show azoospermia associated with 
germ cell loss, this phenotype was also complemented by researchers who carried out 
mutational analysis of human patients with azoospermia (Miyamoto et al., 2015). Our 
results and findings implicate a role for PLK4 in MSCI, the process of transcriptional 
inactivation of homologs that fail to synapse during meiosis and in this case the 
heterologous X and Y chromosome in the male germ cell. This process of MSCI is 
thought to act as a meiotic surveillance mechanism to prevent the generation of 
aneuploid gametes and eliminate defective meiotic cells (Nagaoka et al., 2012). Various 
studies have shown pachytene stage arrest and apoptosis in mouse mutants where 
MSCI fails indicating the process as essential for male meiosis and failure to properly 
execute this mechanism is associated with meiotic arrest and eventually causes male 
infertility (Royo et al., 2010). In conclusion, a better understanding of the function of 
PLK4 and other proteins involved in MSCI, their mechanism and action, would lead to 
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advances and solutions to infertility, reduce incidences of sex chromosome aneuploidy 
and improve reproductive health in general. 
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